Cancer starts when a single cell accumulates enough damage to its DNA that it breaks free from the body’s normal growth controls. This doesn’t happen all at once. It’s a slow, multi-step process where a cell picks up one genetic error, then another, then another, until the combined effect lets it divide without restraint. Most cells that sustain DNA damage either repair themselves or self-destruct. Cancer is what happens when both of those safety systems fail.
Your Cells Have a Gas Pedal and a Brake
Every cell in your body carries two broad categories of genes that keep growth in check. The first category, called proto-oncogenes, tells cells when to grow and divide. Think of them as the gas pedal. The second category, tumor suppressor genes, tells cells when to stop dividing or when to die. They’re the brake pedal.
Cancer typically requires damage to both systems. When a proto-oncogene mutates or gets copied too many times, it can get stuck in the “on” position, becoming what’s called an oncogene. The cell now has a gas pedal jammed to the floor. When a tumor suppressor gene stops working, the brakes fail too. A cell with a stuck accelerator and no brakes divides relentlessly, and that’s the seed of a tumor.
Neither defect alone is usually enough. A cell with a jammed gas pedal but working brakes can often still stop itself. A cell with broken brakes but a normal gas pedal may not be dividing fast enough to cause problems. Cancer generally needs several of these hits to accumulate in the same cell before things truly go wrong.
How DNA Gets Damaged in the First Place
Your body copies its entire genome every time a cell divides, and the human genome contains roughly 3 billion base pairs. Even with remarkably accurate copying machinery, each cell division produces somewhere between 0.1 and 1 new mutations. Over a lifetime of trillions of cell divisions, errors are inevitable. Most land in stretches of DNA that don’t do anything critical. Occasionally, one hits a gene that matters.
External factors accelerate this process. Carcinogens from tobacco smoke, for example, don’t just vaguely “damage” DNA. Chemicals like benzo[a]pyrene get converted by the body’s own enzymes into reactive molecules that physically bind to DNA, forming structures called adducts. These adducts distort the DNA strand so that when the cell copies it, the wrong genetic “letter” gets inserted. Research has shown that tobacco-derived adducts cause specific mutations in two of the most important cancer-related genes: K-ras (a growth accelerator) and p53 (a critical tumor suppressor).
Ultraviolet radiation from sunlight works differently but with the same result. UV energy causes neighboring DNA letters to fuse together, creating kinks that lead to copying errors. Other carcinogens, from alcohol to certain industrial chemicals, each have their own mechanism for introducing mutations, but the endpoint is the same: permanent changes to the DNA code that the cell passes on every time it divides.
The Three Stages of Tumor Formation
Scientists describe the birth of a cancer in three overlapping phases: initiation, promotion, and progression.
Initiation is the moment a stem cell or long-lived cell picks up an irreversible change to its DNA that makes it susceptible to becoming cancerous. This is a brief event. A single exposure to a carcinogen, or a single copying error during division, can be enough. The cell looks and acts normal afterward. It just carries a hidden vulnerability.
Promotion is a longer process where repeated exposures to growth-stimulating signals push that initiated cell to start behaving abnormally. Chronic inflammation, hormonal signals, or continued carcinogen exposure can all act as promoters. During this phase, the cell develops the ability to override its own growth controls. The order matters: promotion without prior initiation doesn’t produce cancer, which is why brief exposures to some carcinogens can be harmless if they aren’t followed by conditions that encourage the damaged cell to keep dividing.
Progression is when the abnormal cell finally becomes a full-blown tumor. The growing mass develops its own blood supply, evades the immune system, and eventually may gain the ability to spread to distant organs. This phase can take years or even decades from the original initiating event.
Why Damaged Cells Don’t Always Die
Your body has a built-in demolition system called programmed cell death. When a cell detects serious DNA damage, it’s supposed to destroy itself before it can pass that damage on. This is one of the body’s most powerful cancer defenses, and cancer cells have to defeat it to survive.
They do this through further mutations that disable the self-destruct machinery. Research has shown that genetic mutations can transform normal stem cells into cells capable of escaping programmed death, which is a prerequisite for tumor formation. Some cancer cells even gain survival advantages from failed attempts at self-destruction. Breast cancer cells that survived exposure to a cell-death trigger in lab studies actually became more aggressive afterward, developing enhanced abilities to spread.
The body also has DNA repair crews that constantly scan for and fix errors. Certain inherited mutations disable these repair systems, leaving cells far more vulnerable to accumulating the kind of damage that leads to cancer. Mutations in the BRCA1 and BRCA2 genes, for instance, cripple a specific repair process that fixes breaks in both strands of the DNA helix. Without this repair pathway, errors pile up with each cell division. That’s why people carrying BRCA mutations face significantly elevated risks of breast, ovarian, prostate, and pancreatic cancers.
Not All Cancer Mutations Come From Outside
There’s a common assumption that cancer is caused primarily by environmental exposures or lifestyle choices. In reality, a substantial fraction of cancer-driving mutations arise from internal processes. Every time a cell divides, the copying machinery can introduce errors that no amount of healthy living would prevent.
That said, roughly two-thirds of the mutations found in tumors are acquired during a person’s lifetime (from copying errors, carcinogens, or other environmental factors), while about one-third may have a germline origin, meaning they were inherited. People with inherited mutations in cancer-related genes don’t start life with cancer, but they start with one of those critical “hits” already in place. They need fewer additional mutations for the process to reach a tipping point.
Genes Can Malfunction Without Mutating
DNA damage isn’t the only way cancer genes get switched on or off. Cells also control gene activity through chemical tags that sit on top of the DNA, essentially a layer of software running on the genetic hardware. These tags, called epigenetic modifications, can silence a gene or amplify it without changing a single letter of the underlying code.
In cancer, one of the most common epigenetic problems is excessive methylation of tumor suppressor genes. Extra chemical tags pile onto the control regions of these genes and shut them down, even though the genes themselves are perfectly intact. Researchers at Johns Hopkins found that every cancer may have 50 to several hundred genes with functional DNA but corrupted epigenetic controls, causing those genes to behave in ways that promote uncontrolled growth.
This discovery opened a different angle on treatment. Because epigenetic changes are, in principle, reversible (unlike mutations), drugs that strip away the silencing tags can sometimes reactivate tumor suppressor genes. Some cancers also feature a single genetic mutation that cascades into widespread epigenetic disruption. Certain brain tumors, for instance, carry a mutation that reshapes the entire epigenetic landscape of the cell, acting as a major driving force behind the cancer even though only one gene was originally affected.
How Many Things Have to Go Wrong
Cancer biologists have identified a set of core capabilities that a cell must acquire to become truly cancerous. The original framework described six: sustaining growth signals, disabling growth suppressors, resisting programmed cell death, achieving unlimited replication, building a blood supply, and gaining the ability to invade other tissues. Three more have been added since: rewiring metabolism to fuel rapid growth, evading the immune system, and unlocking the ability to change cell identity.
No single mutation grants all of these abilities. A developing cancer cell accumulates changes over time, sometimes over 10 to 30 years, picking up one capability after another. This is why cancer is overwhelmingly a disease of aging. The longer cells divide, the more opportunities there are for the necessary mutations to accumulate in one unlucky cell line. It also explains why cancer can seem to appear suddenly even though the process started long before any symptoms emerged. By the time a tumor is large enough to detect, it has been building quietly for years.